Published 2024-01-04
Henry Pramana Sawkar Vijay Pramod Ferry Safriadi


Objective: This study aims to assess the urologist role on tobacco screening and smoking cessation among bladder cancer patients in Indonesia. Material & Methods: A questionnaire regarding tobacco uses screening and smoking cessation recommendation practice patterns was sent to urologists in Indonesia via Ikatan Ahli Urologi Indonesia (IAUI) or Indonesian Urological Association (IUA). The survey was established by Google Form and was sent by email. Responses were automatically integrated to Google spreadsheet. Results: Total of 111 responses from 569 urologists in Indonesia were received, and of the respondents 96% were male and 4% were female. 70% urologists always educate their patients about smoking as one of risk factor for bladder cancer and only 4% never did it. Most common answer for the reason is patients never ask their urologists about it (7%). More than half (59%) of urologists sometimes discuss smoking cessation and 78% always recommend quitting smoking. The majority of responders have never smoked cigarettes (56%), 35% were former smokers, and 9% were current smokers. Conclusion: This study revealed that majority of urologists always educate that smoking is one of risk factor for bladder cancer and recommend to quit smoking. However, only 37% always discuss tobacco use cessation with their patients. Keywords: Tobacco use, smoking cessation, bladder cancer, urologist.



Tobacco use, smoking cessation, bladder cancer, urologist


World Health Organization (WHO). Toolkit for delivering the 5A ’ s and 5R ’ s brief tobacco interventions in primary care. 2014; 17.

Chang SS. Re: Smoking Cessation: A Report of the Surgeon General. J Urol. 2020; 204(2): 384–384.

Bjurlin MA, Goble SM, Hollowell CMP. Smoking cessation assistance for patients with bladder cancer: A national survey of American urologists. J Urol. 2010; 184(5): 1901–6.

World Health Organization (WHO). WHO Statement: World No Tobacco Day 2020. WHO. 2020.

Organization WH. Quit Smoking. WHO. [cited 2022 Mar 14]. Available from:

Sadarang RAI. Factors associated with quitting smoking in indonesia. J Prev Med Public Heal. 2021; 54(2): 137–44.

Mobley D, Baum N. Smoking: Its Impact on Urologic Health. Rev Urol [Internet]. 2015; 17(4): 220–5.

Novesar AR, Pramod SV, Safriadi F. Cigarettes Smoking Pattern in Patient with Urothelial Carcinoma of the Bladder after Smoking Cessation in Tertiary Hospital. 2022; 6(0): 253–61.

Islami F, Stoklosa M, Drope J, Jemal A. Global and Regional Patterns of Tobacco Smoking and Tobacco Control Policies. Eur Urol Focus. 2015; 1(1): 3–16.

(CDC). C for DC and P. Current cigarette smoking among adults - United States. MMWR Morb Mortal Wkly Rep. 2012; 61: 889–94.

Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A. Association between smoking and risk of bladder cancer among men and women. JAMA - J Am Med Assoc. 2011; 306(7): 737–45.

Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, et al. Association of a Comprehensive Smoking Cessation Program with Smoking Abstinence among Patients with Cancer. JAMA Netw Open. 2019; 2(9): 1–14.

Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane database Syst Rev. 2008 Apr; (2): CD000165.

Chen C-H, Shun C-T, Huang K-H, Huang C-Y, Tsai Y-C, Yu H-J, et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int. 2007 Aug; 100(2): 281–6; discussion 286.

Furberg H, Petruzella S, WHiting K, Stein E, Al. E. Association of Biochemically Verified Post-Diagnosis Smoking and Nonmuscle-Invasive Bladder Cancer Recurrence Risk. Am Urol Assoc. 2022; 1178.

Bjurlin MA, Cohn MR, Kim DY, Freeman VL, Lombardo L, Hurley SD, et al. Brief smoking cessation intervention: A prospective trial in the urology setting. J Urol. 2013; 189(5): 1843–9.

Copyright Information
Department of Urology, Faculty of Medicine/Airlangga University